Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Meng-Xin Lin"'
Autor:
Da-Wu Zeng, Zu-Xiong Huang, Meng-Xin Lin, Na-Ling Kang, Xin Lin, Ya-Nan Li, Yue-Yong Zhu, Yu-Rui Liu
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) in the immune-tolerant (IT) phase is significantly associated with high risk for hepatocellular carcinoma, suggesting requirement for antiviral therapy, particularly for tho
Externí odkaz:
https://doaj.org/article/d7239770863949efb47deeacccdf93ef
Autor:
Na-Ling Kang, Qing-Fa Ruan, De-Sheng Zhang, Xue-Ping Yu, Zhen-Ting Hu, Zhi-Min Lin, Lu-Ying Wu, Meng-Xin Lin, Zu-Xiong Huang, Jia-Ji Jiang, Yu-Rui Liu, Ri-Cheng Mao, Da-Wu Zeng
Publikováno v:
Journal of clinical and translational hepatology. 10(3)
Aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) are widely used to assess liver fibrosis in chronic hepatitis B virus (HBV) infection. Currently, the definition of normal alanine aminotransferase (ALT) is contro
Autor:
Yueyong Zhu, Meng-Xin Lin, Yu-Rui Liu, Na-Ling Kang, Zu-Xiong Huang, Jie-Min Zhang, Da-Wu Zeng, Xu-Dong Chen
Publikováno v:
World Journal of Gastroenterology
Background The presence of significant liver fibrosis in hepatitis B virus (HBV)-infected individuals with persistently normal serum alanine aminotransferase (PNALT) levels is a strong indicator for initiating antiviral therapy. Serum ceruloplasmin (
Autor:
Zhangchi Pan, Qing-Qing Weng, Qing Liu, Yao Wang, Chun-Mei Shi, Meng-Xin Lin, Qiang Chen, Tao Jiang, Yan-Qin Lan, Songfei Shen
Publikováno v:
Translational Cancer Research
Background Gastric cancer is a highly heterogeneous disease and its traditional histopathological classification is difficult to meet clinical needs. Oxaliplatin is an antitumor drug with high efficiency and low toxicity. Therefore, the insensitivity
Autor:
Na-Ling Kang, Da-Wu Zeng, Xin Lin, Meng-Xin Lin, Ya-Nan Li, Zu-Xiong Huang, Yueyong Zhu, Yu-Rui Liu
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) in the immune-tolerant (IT) phase is significantly associated with high risk for hepatocellular carcinoma, suggesting requirement for antiviral therapy, particularly for tho
Autor:
Zu-Xiong Huang, Yu-Rui Liu, Na-Ling Kang, Meng-Xin Lin, Jing Dong, Jie-Min Zhang, Da-Wu Zeng, Yueyong Zhu
Publikováno v:
SSRN Electronic Journal.
Background: Hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) in the immune-tolerant (IT) phase is significantly associated with high risk for hepatocellular carcinoma (HCC), suggesting requirement for antiviral therapy particularly fo